IL24 and metabolic dysfunction-associated steatohepatitis: These findings indicate, for the first time, the protective role of IL-24 in MASH pathogenesis and, importantly, delineate its therapeutic mechanism involving the coordinated regulation of autophagy-lysosome function and metabolic reprogramming.